Cellia Science
Kelly Mabry is currently the Chief Executive Officer at Cellia Science and an Executive In Residence at VIC Technology Venture Development™. Previously, Kelly served as the Director of Research and Development at Tangible Science LLC, focusing on the development of innovative contact lenses and lens care products. Kelly's background includes conducting research on heart valve cells during their time as a Graduate Student at the University of Colorado at Boulder and working on process validation experiments for vaccine development at Merck. Kelly holds a PhD in Chemical and Biological Engineering from the University of Colorado at Boulder.
This person is not in any teams
This person is not in any offices
Cellia Science
Cellia Science provides a label-free technology that brings rapid, accurate blood cell assays out of the lab and into the clinic. It also performs 5-part white blood cell differentials and platelet counts for patients to get results in minutes.The company was founded in 2021 and is headquartered in Fayetteville, Arkansas.